Article
Confirmation of a second locus for CMT2 and evidence for additional genetic heterogeneity.
Neurogenetics - 1 Sept 1997
Pericak-Vance M A, Speer M C, Lennon F, West S G, Menold M M, Stajich J M, Wolpert C M, Slotterbeck B D, Saito M, Tim R W, Rozear M P, Middleton L T, Tsuji S, Vance J M
Abstract excerpt
The Charcot-Marie-Tooth (CMT) neuropathies are a group of disorders exhibiting neurophysical, pathological and genetic heterogeneity. CMT2 is a diagnostic subtype of this group of disorders characterized by variable expression and age-of-onset and normal or slightly diminished nerve conduction velocities. Previously, linkage and heterogeneity had been reported in CMT2 with linked families localizing to chromosome...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
